Close Menu

Rise of the CRO

More and more drugmakers are outsourcing their drug trials to contract research organizations, says Pharmalot's Ed Silverman. So it should come as no surprise that CROs are the latest sector to see some large acquisitions and interest from investors.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

As we enter conference season, Nature News asks why graduate students and postdocs are sometimes forced to choose between paying the rent and paying to attend important meetings.

A new analysis says that a 2018 study claiming to show biparental mtDNA inheritance has several flaws.

In PNAS this week: a genome sequence analysis of Crucihimalaya himalaica, multicellularity and fruiting body development in mushroom-forming fungi, and more.

Two researchers are calling for education for scientists on defending facts.